This study tested a high-dose capsaicin patch (Qutenza) against a low-dose version in 409 adults with moderate to severe nerve pain after surgery. The goal was to see if the patch could safely reduce daily pain over 12 weeks. Results are complete, offering insights into a non-dru…
Phase: PHASE3 • Sponsor: Averitas Pharma, Inc. • Aim: Symptom relief
Last updated May 12, 2026 13:44 UTC